InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
CVT | Ann: Ongoing Disclosure Notices - Multiple | 20/03/19 | 0 | 36 | |||
|
|||||||
CVT | Ann: Comvita Announces Half Year Result | 26/02/19 | 0 | 117 | |||
|
|||||||
CVT | Ann: Ongoing Disclosure Notices - Multiple | 20/02/19 | 0 | 149 | |||
|
|||||||
CVT | Ann: Comvita Half Year results, conference call details | 19/02/19 | 0 | 114 | |||
|
|||||||
CVT | Ann: 124,375 partly paid redeemable ordinary shares redeemed | 18/02/19 | 0 | 110 | |||
|
|||||||
CVT | Ann: Notice of redemption of partly paid shares | 11/02/19 | 0 | 116 | |||
|
|||||||
CVT | Ann: Ongoing Disclosure Notices - Multiple | 24/01/19 | 0 | 133 | |||
|
|||||||
CVT | Ann: D&O Ongoing Disclosure for Chris Fleury | 09/01/19 | 0 | 142 | |||
|
See All Discussions